ROSENTHAL BOB 4

What Happened
Bob Rosenthal, a director of Bruker Corporation (BRKR), was granted 4,520 restricted stock units (RSUs) on February 15, 2026. The Form 4 reports an award/acquisition (code A) of 4,520 shares at $0.00 (reported acquisition value $0). This is a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: February 15, 2026 (Filed with SEC on February 18, 2026).
• Transaction type/code: Grant / Award (A).
• Shares granted: 4,520 RSUs; price reported: $0.00; reported transaction value: $0.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: The grant is RSUs that will vest in one installment on February 15, 2027; on vesting each RSU converts into one share of common stock (Footnote F1).
• Filing timeliness: Filed three days after the transaction date; Form 4s are generally required within two business days, so this filing may be late.

Context
RSUs are a form of equity compensation that convert into shares only if and when they vest; there is no immediate cash outlay or share transfer at grant. Such awards are routine for compensation and do not by themselves indicate buying or selling intent in the market. Retail investors should note the vest date (Feb 15, 2027) as the point when shares will be issued and potentially taxable to the recipient.